Homocysteine and Risk in End-stage Renal Disease: a Matter of Context.
From: Istituto di Biomedicina-Epidemiologia e Fisiopatologia Clinica delle Malattie Renali e dell’Ipertensione Arteriosa e Unità Operativa di Nefrologia, Dialisi e Trapianto Renale, Ospedali Riuniti, Reggio Calabria, Italy. carmine.zoccali@tin.it
Kidney international
- Publish Date: Jan 2006
- ISSN: 0085-2538
- Volume: 69
- Issue: 2
- Pages: 204-6
- Medium: Print
- Language: English
- Citation (JAMA): Zoccali C, Mallamaci F, et al. Homocysteine and Risk in End-stage Renal Disease: a Matter of Context.. Kidney Int. Jan 2006;69:204-6
Abstract
Like blood pressure and cholesterol, homocysteine shows a paradoxical inverse relationship with cardiovascular complications in end-stage renal disease (ESRD). A paper by Ducloux et al. in this issue adds perhaps decisive evidence on malnutrition-hypoalbuminemia as the main factor explaining the counterintuitive association between homocysteine and clinical outcome reported in previous studies.
Mesh Headings (Keywords): Blood Pressure, Cardiovascular Diseases, Homocysteine, Humans, Hyperhomocysteinemia, Inflammation, Kidney Failure, Chronic, Malnutrition, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 16408106
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.